Arcadia Biosciences (NASDAQ:RKDA) Receives “Sell (D-)” Rating from Weiss Ratings

Weiss Ratings restated their sell (d-) rating on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Tuesday,Weiss Ratings reports.

Arcadia Biosciences Trading Up 10.5%

Shares of Arcadia Biosciences stock opened at $3.69 on Tuesday. The firm has a fifty day simple moving average of $3.79 and a 200-day simple moving average of $3.97. Arcadia Biosciences has a 1-year low of $2.53 and a 1-year high of $10.31. The stock has a market capitalization of $5.06 million, a price-to-earnings ratio of -0.86 and a beta of 0.53.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings data on Thursday, August 14th. The basic materials company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.79) by $0.81. Arcadia Biosciences had a negative net margin of 139.36% and a negative return on equity of 34.75%. The business had revenue of $1.46 million during the quarter, compared to analysts’ expectations of $1.60 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.